Skip to main content

Table 4 Qualitative analysis of the occurrence of at least 1 uveitis before and during the first year of TNF inhibitor treatment in patients with SpA or PsA

From: Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort

  

Uveitis ≥ 1 during the first year of TNF inhibitor

Yes

No

p

Uveitis ≥ 1 in the year before TNF inhibitor

Yes

10

17

0.17

No

9

325